[144] Arteris, Inc. SEC Filing

Rhea-AI Filing Summary

Arteris, Inc. filing of Form 144 notifies the market of a proposed sale of 4,750 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $53,485.00. The sale is to occur on or about 10/03/2025 on NASDAQ. The shares were acquired as Restricted Stock Units on 10/01/2025 from the issuer and are listed as 4,750 units in the notice. The filing also discloses multiple recent sales by the same person, Paul Alpern, during the past three months with individual sale dates and proceeds provided.

The form includes the seller's representation that no undisclosed material adverse information is known and provides broker contact details; it documents compliance with Rule 144 sale notice requirements rather than presenting operational or financial performance data.

Insights

Securities Compliance Counsel

Form 144 documents a planned Rule 144 sale of restricted shares and recent insider dispositions.

The filing shows a proposed sale of 4,750 common shares on 10/03/2025 via Morgan Stanley Smith Barney LLC, and confirms acquisition of those shares as Restricted Stock Units on 10/01/2025. This satisfies the Rule 144 notice requirement to disclose the proposed transaction and broker details.

The signer also affirms no undisclosed material adverse information; that representation is standard and legally significant because it accompanies the Rule 144 sale notice.

Insider Transaction Analyst

File lists multiple recent sales by the same person, showing ongoing dispositions over the past three months.

The filing itemizes prior sales by Paul Alpern on 09/02/2025, 09/08/2025, 09/09/2025, 09/15/2025, 10/01/2025, and 10/02/2025 with stated share counts and gross proceeds, providing a clear transaction history for the insider.

This record is factual and allows monitoring of insider selling patterns; the planned sale date of 10/03/2025 is a concrete, monitorable item disclosed in the notice.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4750	53485.00	42649917	10/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	Restricted Stock Units	Issuer			4750	10/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PAUL ALPERN 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	10/02/2025	2877	31419.14
10b5-1 Sales for PAUL ALPERN 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	10/01/2025	5000	51544.50
10b5-1 Sales for PAUL ALPERN 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/15/2025	10000	88805.00
10b5-1 Sales for PAUL ALPERN 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/09/2025	2278	19793.66
10b5-1 Sales for PAUL ALPERN 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/08/2025	424	3807.52
PAUL ALPERN 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/02/2025	258	2306.96

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Arteris' (AIP) Form 144 disclose about the planned sale?

The filing discloses a proposed sale of 4,750 common shares with an aggregate market value of $53,485.00, to occur on or about 10/03/2025 on NASDAQ via Morgan Stanley Smith Barney LLC.

How were the 4,750 shares being sold acquired?

The filing states the shares were acquired as Restricted Stock Units from the issuer on 10/01/2025.

Who has been selling Arteris shares recently according to the filing?

The filing lists multiple sales by Paul Alpern on 09/02/2025, 09/08/2025, 09/09/2025, 09/15/2025, 10/01/2025, and 10/02/2025 with stated share counts and gross proceeds.

What broker will execute the proposed sale?

The broker named in the notice is Morgan Stanley Smith Barney LLC, address listed as 1 New York Plaza 8th Floor New York NY 10004.

Does the filing include a representation about undisclosed information?

Yes. The person for whose account the securities are to be sold represents by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed.